Session Abstract – PMWC 2022 Silicon Valley


The COVID-19 pandemic is driving unprecedented transformation of the global medical research ecosystem through the search for effective new therapeutics that can help ease symptoms and prevent death among COVID-19 patients. This Showcase will include a selected number of companies that are developing breakthrough treatments for COVID-19.


Confirmed Presenting Companies:

 Session Chair Profile

M.D., MPH, Executive Director, Clinical Research, Gilead Sciences

Biography
Executive director of clinical research leading the Emerging and Respiratory Viruses group in the Virology therapeutic area at Gilead Sciences, Inc. Anu is an infectious diseases physician with over 15 years of experience in infectious diseases, liver diseases, public health and drug development. In her current role, she oversees development efforts for COVID-19 including Remdesivir. She is the author of over 70 scientific publications and has a passion for rapidly advancing transformative therapies.